Cellenis® PRGF System: Product and Application Guide

What is Cellenis® PRGF System?

Cellenis® PRGF system is an autolog cellular treatment system developed to eliminate unwanted components that may negatively affect the healing process such as red blood cells (RBC), leukosit and neutrophil while isolate platelets with the highest efficiency.

Working mechanism

• Effectively stimulates the development of new blood vessel in the target tissue (angiogenesis).
• It thickens the epidermis by triggering tissue repair and new collagen synthesis, improves skin texture, elasticity and tone.
• With a standardized centrifuge process, a biologically rich autolog cell reapplication is achieved.

Advantages of Cellenis® PRGF System

• Excellent cell gain: 80% of platelets in the blood sample (±10), allowing maximum growth factor to be achieved.
• Quick and practical protocol: Only 10 minutes centrifuge time with single turn cycle is ready to apply.
• Patient comfort and safety: Minimum blood sample is sufficient; it is a completely biological, pyrogen-free, non- additive and chemical modification-free method.
• Excellent cost value: Approximately 6 ml from 11 ml tube, about 13 ml pure PRP/PRGF is obtained from 22 ml tube.
• Consistent and customizable concentration: Independent from the operator to 5 floors (and to 5X) offer intensive results.

Tactile Effects of Growth Factors

Product Structure and Tube Technology

• Vacuum sterile special glass structure: The platelets are coated early adhesion to the tube inner wall and prevent the timeless degranulation.
• Modified anticoagulant formulation: The acidity rate is optimized; when the thrombocy is maintained, the burning sensation in the injection is eliminated.
• Patented physical separator filter gel: More than 80% of thrombocytes keep in the upper phase, the 99%,9% of red blood cells are pilled into the base (the PRP gold yellow color) and filters 92-96 of neutrophils.

Cell Count and Growth Factor Statistical Analysis Home

The following data reflects the average of approved tests and clinical analysis in independent laboratories.

Clinical Application Protocols and Results

The FDA approved Class II and CE certified Class IIb medical device status system provides a standard, reliable and operator independent workflow for clinics. Pain and inflammatory reactions are minimized in tissue injections thanks to physiological pH balance.

Tricological applications

After a total of 3 sessions treatment protocols applied for 4 weeks, the hair follicle density in the target area and statistically significant increase in hair wire thickness is recorded. In 5 sessions, the first application was observed that the quality of hair is maintained at high rate even after 6 months.

Dermatological and aesthetic skin applications

After 3 months of microinjection applications made in the submental (food) region, marked toning, elasticity increase and tightening are monitored. In the treatment of acne scars and epidermal spots, 2 months after the first application, noticeable improvement was detected in skin smoothness and tone equality.